Abstract: Fusarium is the most common mold in clinical practice, which may cause superficial infection in hosts with normal immune function, such as keratitis and severe disseminated infection (primarily manifested as fungemia) in individuals with poor immune function. Prevention and treatment of fusaridiosis are associated with long-term survival of kidney transplant recipients. To promote the standardization of clinical diagnosis and treatment of invasive fusaridiosis in kidney transplant recipients, Branch of Organ Transplantation of Chinese Medical Association initiated and formulated “Guidelines for Clinical Diagnosis and Treatment of Invasive Fusaridiosis in Kidney Transplant Recipients in China”. In this guideline, the levels of evidence and strengths of recommendation for each clinical problem were classified using Oxford Center for Evidence-based Medicine of 2009. Regarding 13 clinical problems related to clinical diagnosis and treatment of invasive fusaridiosis after kidney transplantation, 14 recommendations were proposed in accordance with clinical diagnosis and treatment practice in China, aiming to promote the standardization of diagnosis and treatment of invasive fusaridiosis after kidney transplantation and improve long-term survival of both recipients and renal allografts after kidney transplantation.